About Us

We are responsible for the design and development of novel biosensor based technologies for the in-vitro diagnostics industry.  Our core specialty resides in the area of Blood Glucose Monitoring Systems.

Our company is located in Singapore, a dynamic city with a vibrant ecosystem strategically located in the heart of the largest growing diabetes markets worldwide. We have thoroughly examined the SMGB field, and believe that Sentec's approach to the disease management is disruptive and will enable the company to leverage this tremendous global market opportunity.

---

Dr. Roobik Azarnia, President

Sentec was founded by Dr. Roobik Azarnia, president and CSO, who has over 25 years of experience and expertise in the in-vitro diagnostics industry (IVD.)  For over 10 years, he directed biosensor and immunomagnetic based R&D at Coulter Corporation of Florida and Immunicon Corporation of Pennsylvania.  Prior to that he was co-founder and president of MegaTechnologies, Inc., a start-up biotech company engaged in home glucose monitoring device development.

Before joining the IVD industry, Dr. Azarnia held a faculty position as Associate Professor of Physiology and Biophysics at the University of Miami School of Medicine.

Dr. Roobik Azarnia

Dr. Robert Ray, Chief Operating Officer

Until recently Dr. Ray was Co-founder, President and CEO of FlexSite Diagnostics. Dr. Ray is a biochemist with over 30 years of experience in the in-vitro diagnostics industry. Prior to founding FlexSite, he was President of CheckPoint Development, Inc., a consulting and contracts development enterprise.  He has also served as Vice President of Home Diagnostics Inc., Business Manager of Coulter’s Chemistry business, President of London Diagnostics, Vice President of R&D for Baxter Dade, and General Manager for Immunosystems at Beckman Instruments. 

Dr. Ray holds a Bachelors degree in Chemistry, a Masters degree in Biochemistry, and a Doctorate in Biochemistry, all from The University of Nebraska.  He is also a graduate of The University of California, Los Angeles Graduate School of Management.

Vincent Cheung, VP Regulatory + Quality

Mr. Cheung has over 15 years of medical device industry experience with various multinational companies such as Edwards Lifesciences, Johnson & Johnson, and B.Braun.  He was actively involved in cardiovascular product development, setting up Class II/III manufacturing operations, quality system management, regulatory affairs and compliance activities.  In 2005, Mr. Cheung was relocated from the United States to Singapore to establish heart valve manufacturing presence in Asia for Edwards Lifesciences where he was instrumental in attaining successful USFDA and Japan PMDA quality system inspection, ISO 13485 Quality Management System certification, and CE Mark audit. 

Mr. Cheung established Applied Quality Systems Pte Ltd, an RA/QA consultancy company in Singapore.  He provides consultancy services in quality management systems and regulatory affairs activities for various small-to-medium medical device companies and the Science a8A*STAR), a leading Singapore government agency. He holds a Bachelors degree in Medical Microbiology from the California State University at Long Beach, is an Executive Committee member of the Biomedical Engineering Society of Singapore, and consultative member for the Bioengineering Department at the National University of Singapore. 

Colin Tan, Project Consultant

Mr. Tan has over 6 years of experience in project engineering and project management at the following: Quattro Vascular, Singapore; Circle Medical Devices, Los Gatos, CA; ALZA Corporation, Johnson & Johnson, Mountain View, CA. His expertise is in managing medical device projects through the major phases of product development. He has extensive experience in leading projects from conceptualization and prototyping, through design verification and validation, to clinical trials, manufacturing and product launch. Projects included glucose monitors, insulin delivery systems, ocular shunt implants, mitral valves, balloon catheters, vascular access ports, gastro-intestinal implants and endoscopy and laparoscopy devices. 

Colin holds a BS in Biomedical Engineering from Northwestern University, and an MS in Bioengineering from Stanford University.